Moreover, it has been demonstrated that higher levels of Lp(a) are correlated with an elevated risk of CVEs across diverse populations, including those with premature or stable CAD, ACS, familial hypercholesterolemia, DM, and so forth [22, 24, 36, 37, 38]. The gene discussed is LPA; the disease is familial hypercholesterolemia.